Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Panitumumab and Bortezomib for Patients With Advanced Colorectal Cancer

This study has been terminated.
(Low accrual--unable to meet accrual goals)
Millennium Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Georgetown University Identifier:
First received: December 14, 2011
Last updated: December 19, 2016
Last verified: February 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2014
  Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)